Tzellos T - Search Results

1

Improved methodology in determining melanoma mortality and selecting patients for immunotherapy.

Dixon AJ, Steinman HK, Kyrgidis A, Smith H, Sladden M, Zouboulis C, Argenziano G, Apalla Z, Lallas A, Longo C, Nirenberg A, Popescu C, Dixon JB, Tzellos T, Zachary C, Cleaver L, Anderson S, Zagarella S, Thomas JM. Dixon AJ, et al. Among authors: tzellos t. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e843-e845. doi: 10.1111/jdv.18951. Epub 2023 Feb 22. J Eur Acad Dermatol Venereol. 2023. PMID: 36785984 No abstract available.

2

New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors, and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence.

Kyrgidis A, Tzellos TG, Vahtsevanos K, Triaridis S. Kyrgidis A, et al. J Surg Res. 2010 Mar;159(1):545-56. doi: 10.1016/j.jss.2008.11.834. Epub 2008 Dec 16. J Surg Res. 2010. PMID: 19285687 Review.

3

Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.

Kyrgidis A, Vahtsevanos K, Tzellos TG, Xirou P, Kitikidou K, Antoniades K, Zouboulis CC, Triaridis S. Kyrgidis A, et al. Eur J Dermatol. 2010 May-Jun;20(3):276-82. doi: 10.1684/ejd.2010.0903. Epub 2010 Apr 20. Eur J Dermatol. 2010. PMID: 20406722

4

Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications.

Kyrgidis A, Tzellos TG, Triaridis S. Kyrgidis A, et al. J Carcinog. 2010 Apr 1;9:3. doi: 10.4103/1477-3163.62141. J Carcinog. 2010. PMID: 20442802 Free PMC article.

5

The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.

Kyrgidis A, Tzellos TG, Toulis K, Antoniades K. Kyrgidis A, et al. J Osteoporos. 2011 Feb 16;2011:147689. doi: 10.4061/2011/147689. J Osteoporos. 2011. PMID: 21403823 Free PMC article.

6

Dermoscopy of solitary cylindroma.

Lallas A, Apalla Z, Tzellos T, Lefaki I. Lallas A, et al. Among authors: tzellos t. Eur J Dermatol. 2011 Jul-Aug;21(4):645-6. doi: 10.1684/ejd.2011.1413. Eur J Dermatol. 2011. PMID: 21697054 No abstract available.

7

Safety and efficacy of zoledronic acid in multiple myeloma.

Kyrgidis A, Tzellos TG. Kyrgidis A, et al. Lancet. 2011 Jun 25;377(9784):2177-8. doi: 10.1016/S0140-6736(11)60958-6. Lancet. 2011. PMID: 21704864 Clinical Trial. No abstract available.

8

New pharmaceutical concepts for sebaceous gland diseases: implementing today's pre-clinical data into tomorrow's daily clinical practice.

Zampeli VA, Makrantonaki E, Tzellos T, Zouboulis CC. Zampeli VA, et al. Among authors: tzellos t. Curr Pharm Biotechnol. 2012 Aug;13(10):1898-913. doi: 10.2174/138920112802273173. Curr Pharm Biotechnol. 2012. PMID: 22250709 Review.

9

Novel antimicrobial agents for the management of maxillofacial and neck infections.

Valasidis AA, Kyrgidis AA, Tzellos TG, Triaridis SK, Antoniades KH. Valasidis AA, et al. Recent Pat Antiinfect Drug Discov. 2012 Aug;7(2):95-103. doi: 10.2174/157489112801619656. Recent Pat Antiinfect Drug Discov. 2012. PMID: 22559299 Review.

10

Denosumab in castration-resistant prostate cancer.

Kyrgidis A, Tzellos TG. Kyrgidis A, et al. Lancet. 2012 May 12;379(9828):e50; author reply e50-1. doi: 10.1016/S0140-6736(12)60764-8. Lancet. 2012. PMID: 22579323 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page